Related Experiment Videos
AIDS: primarily a viral or an autoimmune disease?
1Medical Biology Institute, La Jolla, CA 92037.
AIDS Research and Human Retroviruses
|May 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Journal of the American Academy of Dermatology·2001
The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study.
AIDS research and human retroviruses·2001
Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter.
Journal of immunology (Baltimore, Md. : 1950)·1997
n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
Acta dermato-venereologica·1996
Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.
AIDS research and human retroviruses·2026
Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China.
AIDS research and human retroviruses·2026
Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.
AIDS research and human retroviruses·2026
Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.
AIDS research and human retroviruses·2026
Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.
AIDS research and human retroviruses·2026
Identification of a Complex HIV-1 Circulating Recombinant Form (CRF203_cpx) Originating from Three Main Circulating Recombinant Forms in China.
AIDS research and human retroviruses·2026
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.
Immunological medicine·2026
Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.
ACG case reports journal·2026